GT Biopharma Inc (GTBP)

[GunHawk]

GT Biopharma is developing a cancer treatment (OXS-1615 & OXSC3550) that aims to kill cancer cells found in solid tumours and also kill cancer stem cells that are often responsible for reoccurring cancer coming back to patients. Another one of their drugs (OXS-1550) is intended for patients with lymphoma or leukemia. 25 patients with lymphoid malignancies received OXS-1550, where one patient's tumor went into partial remission, while a second patient's tumor went into complete remission and disappeared. While their early studies showed some success, remission of 2 patients is not necessarily enough to prove that this formula can consistently cure patients with lymphoma or leukemia.

I put my trust in $GTBP on fighting cancer!